NCT03975959 2025-09-23PROMESSEInstitut du Cancer de Montpellier - Val d'AurellePhase NA Completed426 enrolled
NCT04521686 2025-06-27Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsEli Lilly and CompanyPhase 1 Active not recruiting200 enrolled
NCT04025541 2025-04-02ALCINA2Institut du Cancer de Montpellier - Val d'AurellePhase NA Recruiting992 enrolled